Pancreatic cancer classification

Pancreatic cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancreatic Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancreatic cancer classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancreatic cancer classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancreatic cancer classification
CDC on Pancreatic cancer classification
Pancreatic cancer classification in the news
Blogs on Pancreatic cancer classification
Directions to Hospitals Treating Pancreatic cancer
Risk calculators and risk factors for Pancreatic cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Classification

• Types of Pancreatic Cancers:

Types of Pancreatic Cancers
Pancreatic Exocrine Cancers
Adenocarcinoma
Acinar cell carcinoma
Adenosquamous carcinoma
Giant cell tumour
Intraductal papillary mucinous neoplasm (IPMN)
Mucinous cystadenocarcinoma
Pancreatoblastoma
Serous cystadenocarcinoma
Solid and pseudopapillary tumours
Pancreatic Endocrine Cancers (Pancreatic Neuroendocrine Tumours)
Gastrinoma
Glucagonoma
Insulinoma
Nonfunctional islet cell tumour
Somatostatinoma
Vasoactive intestinal peptide releasing tumour (VIPoma)

• Types of Pancreatic Intraepithelial Neoplasia (PanIN):

Types of Pancreatic Intraepithelial Neoplasia (PanIN)
PanIN 1 (low grade)
Minimal degree of atypia
Subclassified into PanIN 1A: absence of micropapillary infoldings of the epithelium; and 1B, presence of micropapillary infoldings of the epithelium
PanIN 2 (intermediate grade)
Moderate degree of atypia, including loss of polarity, nuclear crowding, enlarged nuclei, pseudostratification, and hyperchromatism
Mitoses are rarely seen
PanIN 3 (high grade/carcinoma in situ)
Severe atypia, with varying degrees of cribriforming, luminal necrosis, and atypical mitoses
Contained within the basement membrane

• TNM classification for pancreatic cancer:

TNM Classification for Pancreatic Cancer:
Primary tumor
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Tis	Carcinoma in situ
T1	Tumor limited to the pancreas, ≤2 cm in greatest dimension
T2	Tumor limited to the pancreas, >2 cm in greatest dimension
T3	Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
T4	Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor)
Regional lymph nodes
NX	Regional lymph nodes cannot be assessed
N0	No regional lymph node metastasis
N1	Regional lymph node metastasis
Distant metastases
MX	Distant metastasis cannot be assessed
M0	No distant metastasis
M1	Distant metastasis

• Stage grouping of pancreatic cancer:

Stage grouping of pancreatic cancer:
Primary tumor
Stage	T	N	M
0	Tis	N0	M0
IA	T1	N0	M0
IB	T2	N0	M0
IIA	T3	N0	M0
IIB	T1	N1	M0
	T2	N1	M0
	T3	N1	M0
III	T4	Any N	M0
IV	Any T	Any N	M1

• Staging and TNM (tumour, lymph node, metastasis) classification related to incidence, treatment, and prognosis:

Staging and TNM Classification related to Incidence, Treatment, and Prognosis
Stage	TNM Classification	Clinical Classification	Incidence at diagnosis (%)	5-year survival rate (%)
0	Tis, N0, M0	Resectable	7.5	15.2
IA	T1, N0, M0	—	—	—
IB	T2, N0, M0	—	—	—
IIA	T3, N0, M0	—	—	—
IIB	T1-3, N1, M0	Locally advanced	29.3	6.3
III	T4, any N, M0	—	—	—
IV	Any T, any N, M1	Metastatic	47.2	1.6

• Functional Pancreatic Neuroendocrine Tumors and their Characteristics are mentioned in the following table:

Functional Pancreatic Neuroendocrine Tumors and their Characteristics
Tumor type and syndrome	Location in pancreas	Signs and symptoms	Circulating biomarkers
Insulinoma (Whipple’s triad)	Head, body, tail (evenly distributed)	Hypoglycemia, dizziness, sweating, tachycardia, tremulousness, confusion, seizure	CgA and CgB, insulin inappropriate for blood glucose level, proinsulin, C-peptide
Gastrinoma (Zollinger–Ellison)	Gastrinoma triangle Often extrapancreatic (duodenal); can be found anywhere in gland	Gastric acid hypersecretion, peptic ulcer, diarrhea, esophagitis, epigastric pain	CgA, gastrin, PP (35%)
VIPoma (Verner– Morrison syndrome, WDHA)	Distal pancreas (body and tail) Often spread outside pancreas	Watery diarrhea, hypokalemia, achlorhydria (or acidosis)	CgA, VIP
Glucagonoma	Body and tail of pancreas Often large and spread outside pancreas	Diabetes (hyperglycemia), necrolytic migratory erythema, stomatitis, glossitis, angular cheilitis	CgA, glucagon, glycentin
Somatostatinoma	Pancreatoduodenal groove, ampullary, periampullary	Gallstones, diabetes (hyperglycemia), steatorrhea	CgA, somatostatin
Ppoma	Head of pancreas	None	CgA, PP